p.104 抽出テキスト
867. Mehanna M, Gong Y, McDonough CW, Beitelshees AL, Gums JG, Chapman AB, et al. Blood pressure response to metoprolol and chlorthalidone in European and African Americans with hypertension. J Clin Hypertens (Greenwich) 2017;19:1301–8. https:// doi.org/10.1111/jch.13094 868. Faconti L, McNally RJ, Farukh B, Adeyemi O, Cruickshank JK, Wilkinson IB, et al. Differences in hypertension phenotypes between Africans and Europeans: role of environment. J Hypertens 2020;38:1278–85. https://doi.org/10.1097/hjh.0000000000002403 869. Schutte AE, Kruger R, Gafane-Matemane LF, Breet Y, Strauss-Kruger M, Cruickshank JK, et al. Ethnicity and arterial stiffness. Arterioscler Thromb Vasc Biol 2020;40:1044–54. https://doi.org/10.1161/atvbaha.120.313133 870. Erlinger TP, Vollmer WM, Svetkey LP, Appel LJ. The potential impact of nonpharmacologic population-wide blood pressure reduction on coronary heart disease events: pronounced benefits in African-Americans and hypertensives. Prev Med 2003;37: 327–33. https://doi.org/10.1016/s0091-7435(03)00140-3 871. The ALLHAT Officers Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002;288: 2981–97. https://doi.org/10.1001/jama.288.23.2981 872. Wright JT Jr, Dunn JK, Cutler JA, Davis BR, Cushman WC, Ford CE, et al. Outcomes in hypertensive black and nonblack patients treated with chlorthalidone, amlodipine, and lisinopril. JAMA 2005;293:1595–608. https://doi.org/10.1001/jama.293.13.1595 873. Wright JT Jr, Harris-Haywood S, Pressel S, Barzilay J, Baimbridge C, Bareis CJ, et al. Clinical outcomes by race in hypertensive patients with and without the metabolic syndrome: antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). Arch Intern Med 2008;168:207–17. https://doi.org/10.1001/archinternmed. 2007.66 874. Ojji DB, Mayosi B, Francis V, Badri M, Cornelius V, Smythe W, et al. Comparison of dual therapies for lowering blood pressure in Black Africans. N Engl J Med 2019; 380:2429–39. https://doi.org/10.1056/NEJMoa1901113 875. van der Linden EL, Couwenhoven BN, Beune E, Daams JG, van den Born B-JH, Agyemang C. Hypertension awareness, treatment and control among ethnic minority populations in Europe: a systematic review and meta-analysis. J Hypertens 2021;39: 202–13. https://doi.org/10.1097/hjh.0000000000002651 876. Agyemang C, Nyaaba G, Beune E, Meeks K, Owusu-Dabo E, Addo J, et al. Variations in hypertension awareness, treatment, and control among Ghanaian migrants living in Amsterdam, Berlin, London, and nonmigrant Ghanaians living in rural and urban Ghana—the RODAM study. J Hypertens 2018;36:169–77. https://doi.org/10.1097/ hjh.0000000000001520 877. van Laer SD, Snijder MB, Agyemang C, Peters RJ, van den Born BH. Ethnic differences in hypertension prevalence and contributing determinants – the HELIUS study. Eur J Prev Cardiol 2018;25:1914–22. https://doi.org/10.1177/2047487318803241 878. Costello HM, Gumz ML. Circadian rhythm, clock genes, and hypertension: recent advances in hypertension. Hypertension 2021;78:1185–96. https://doi.org/10.1161/ hypertensionaha.121.14519 879. O’Brien E, Sheridan J, O’Malley K. Dippers and non-dippers. Lancet 1988;2:397. https:// doi.org/10.1016/s0140-6736(88)92867-x 880. Pickering TG, Shimbo D, Haas D. Ambulatory blood-pressure monitoring. N Engl J Med 2006;354:2368–74. https://doi.org/10.1056/NEJMra060433 881. Abdalla M, Goldsmith J, Muntner P, Diaz KM, Reynolds K, Schwartz JE, et al. Is isolated nocturnal hypertension a reproducible phenotype? Am J Hypertens 2016;29:33–8. https://doi.org/10.1093/ajh/hpv058 882. Mancia G, Facchetti R, Bombelli M, Quarti-Trevano F, Cuspidi C, Grassi G. Short- and long-term reproducibility of nighttime blood pressure phenotypes and nocturnal blood pressure reduction. Hypertension 2021;77:1745–55. https://doi.org/10.1161/ hypertensionaha.120.16827 883. Nolde JM, Kiuchi MG, Lugo-Gavidia LM, Ho JK, Chan J, Matthews VB, et al. Nocturnal hypertension: a common phenotype in a tertiary clinical setting associated with increased arterial stiffness and central blood pressure. J Hypertens 2021;39:250–8. https://doi.org/10.1097/hjh.0000000000002620 884. Thomas SJ, Booth JN III, Jaeger BC, Hubbard D, Sakhuja S, Abdalla M, et al. Association of sleep characteristics with nocturnal hypertension and nondipping blood pressure in the CARDIA study. J Am Heart Assoc 2020;9:e015062. https://doi.org/10.1161/jaha. 119.015062 885. Kario K, Hoshide S, Haimoto H, Yamagiwa K, Uchiba K, Nagasaka S, et al. Sleep blood pressure self-measured at home as a novel determinant of organ damage: Japan morning surge home blood pressure (J-HOP) study. J Clin Hypertens (Greenwich) 2015;17: 340–8. https://doi.org/10.1111/jch.12500 886. de la Sierra A, Gorostidi M, Banegas JR, Segura J, de la Cruz JJ, Ruilope LM, et al. Nocturnal hypertension or nondipping: which is better associated with the cardiovascular risk profile? Am J Hypertens 2014;27:680–7. https://doi.org/10.1093/ajh/hpt175 887. Wijkman M, Länne T, Engvall J, Lindström T, Östgren CJ, Nystrom FH, et al. Masked nocturnal hypertension—a novel marker of risk in type 2 diabetes. Diabetologia 2009;52:1258–64. https://doi.org/10.1007/s00125-009-1369-9 888. Muntner P, Lewis CE, Diaz KM, Carson AP, Kim Y, Calhoun D, et al. Racial differences in abnormal ambulatory blood pressure monitoring measures: results from the coronary artery risk development in young adults (CARDIA) study. Am J Hypertens 2015;28:640–8. https://doi.org/10.1093/ajh/hpu193 889. Thomas SJ, Booth JN III, Bromfield SG, Seals SR, Spruill TM, Ogedegbe G, et al. Clinic and ambulatory blood pressure in a population-based sample of African Americans: the Jackson heart study. J Am Soc Hypertens 2017;11:204–212.e205. https://doi.org/ 10.1016/j.jash.2017.02.001 890. Husain A, Lin FC, Tuttle LA, Olsson E, Viera AJ. The reproducibility of racial differences in ambulatory blood pressure phenotypes and measurements. Am J Hypertens 2017; 30:961–7. https://doi.org/10.1093/ajh/hpx079 891. Li Y, Wang JG. Isolated nocturnal hypertension: a disease masked in the dark. Hypertension 2013;61:278–83. https://doi.org/10.1161/hypertensionaha.111.00217 892. Hoshide S, Kario K, de la Sierra A, Bilo G, Schillaci G, Banegas JR, et al. Ethnic differences in the degree of morning blood pressure surge and in its determinants between Japanese and European hypertensive subjects: data from the ARTEMIS study. Hypertension 2015;66:750–6. https://doi.org/10.1161/hypertensionaha.115.05958 893. Banegas JR, Ruilope LM, de la Sierra A, Gorostidi M, Segura J, Martell N, et al. High prevalence of masked uncontrolled hypertension in people with treated hypertension. Eur Heart J 2014;35:3304–12. https://doi.org/10.1093/eurheartj/ehu016 894. Huang JF, Zhang DY, Sheng CS, An D-W, Li M, Cheng Y-B, et al. Isolated nocturnal hypertension in relation to host and environmental factors and clock genes. J Clin Hypertens (Greenwich) 2022;24:1255–62. https://doi.org/10.1111/jch.14532 895. Matsumoto T, Tabara Y, Murase K, Setoh K, Kawaguchi T, Nagashima S, et al. Nocturia and increase in nocturnal blood pressure: the Nagahama study. J Hypertens 2018;36: 2185–92. https://doi.org/10.1097/hjh.0000000000001802 896. Seif F, Patel SR, Walia HK, Rueschman M, Bhatt DL, Blumenthal RS, et al. Obstructive sleep apnea and diurnal nondipping hemodynamic indices in patients at increased cardiovascular risk. J Hypertens 2014;32:267–75. https://doi.org/10. 1097/hjh.0000000000000011 897. Kimura G, Dohi Y, Fukuda M. Salt sensitivity and circadian rhythm of blood pressure: the keys to connect CKD with cardiovascular events. Hypertens Res 2010;33:515–20. https://doi.org/10.1038/hr.2010.47 898. Drawz PE, Alper AB, Anderson AH, Brecklin CS, Charleston J, Chen J, et al. Masked hypertension and elevated nighttime blood pressure in CKD: prevalence and association with target organ damage. Clin J Am Soc Nephrol 2016;11:642–52. https://doi. org/10.2215/cjn.08530815 899. Kanno A, Metoki H, Kikuya M, Terawaki H, Hara A, Hashimoto T, et al. Usefulness of assessing masked and white-coat hypertension by ambulatory blood pressure monitoring for determining prevalent risk of chronic kidney disease: the Ohasama study. Hypertens Res 2010;33:1192–8. https://doi.org/10.1038/hr.2010.139 900. Kushiro T, Kario K, Saito I, Teramukai S, Sato Y, Okuda Y, et al. Increased cardiovascular risk of treated white coat and masked hypertension in patients with diabetes and chronic kidney disease: the HONEST study. Hypertens Res 2017;40:87–95. https://doi. org/10.1038/hr.2016.87 901. Lurbe E, Redon J, Kesani A, Pascual JM, Tacons J, Alvarez V, et al. Increase in nocturnal blood pressure and progression to microalbuminuria in type 1 diabetes. N Engl J Med 2002;347:797–805. https://doi.org/10.1056/NEJMoa013410 902. Cuspidi C, Sala C, Tadic M, Gherbesi E, De Giorgi A, Grassi G, et al. Clinical and prognostic significance of a reverse dipping pattern on ambulatory monitoring: an updated review. J Clin Hypertens (Greenwich) 2017;19:713–21. https://doi.org/10. 1111/jch.13023 903. Wu Q, Hong M, Xu J, Tang X, Zhu L, Gao P, et al. Diurnal blood pressure pattern and cardiac damage in hypertensive patients with primary aldosteronism. Endocrine 2021; 72:835–43. https://doi.org/10.1007/s12020-021-02606-3 904. Kario K, Hoshide S, Mizuno H, Kabutoya T, Nishizawa M, Yoshida T, et al. Nighttime blood pressure phenotype and cardiovascular prognosis: practitioner-based nationwide JAMP study. Circulation 2020;142:1810–20. https://doi.org/10.1161/ circulationaha.120.049730 905. Kario K, Hoshide S, Nagai M, Okawara Y, Kanegae H. Sleep and cardiovascular outcomes in relation to nocturnal hypertension: the J-HOP nocturnal blood pressure study. Hypertens Res 2021;44:1589–96. https://doi.org/10.1038/s41440-021-00709-y 906. Wang Q, Wang Y, Wang J, Zhang L, Zhao MH. Nocturnal systolic hypertension and adverse prognosis in patients with CKD. Clin J Am Soc Nephrol 2021;16:356–64. https://doi.org/10.2215/cjn.14420920 907. Hansen TW, Li Y, Boggia J, Thijs L, Richart T, Staessen JA. Predictive role of the nighttime blood pressure. Hypertension 2011;57:3–10. https://doi.org/10.1161/hypertensionaha. 109.133900 908. Staessen JA, Thijs L, Fagard R, O’Brien ET, Clement D, de Leeuw PW, et al. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. JAMA 1999;282:539–46. https://doi.org/10.1001/jama.282.6.539 909. Verdecchia P, Porcellati C, Schillaci G, Borgioni C, Ciucci A, Battistelli M, et al. Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension. Hypertension 1994;24:793–801. https://doi.org/10.1161/01.hyp.24.6.793 910. Ohkubo T, Hozawa A, Yamaguchi J, Kikuya M, Ohmori K, Michimata M, et al. Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study. J Hypertens 2002;20: 2183–9. https://doi.org/10.1097/00004872-200211000-00017 ESC Guidelines 4015 Downloaded from academic.oup.com/eurheartj/article/45/38/3912/7741010 by guest on 07 October 2026